Europe Anemia Drugs Market Report 2016

November 2016 | 102 pages | ID: E2485264C37EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anemia Drugs

Revenue, means the sales value of Anemia Drugs

This report studies sales (consumption) of Anemia Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• GlaxoSmithKline
• Bluebird bio
• GlycoMimetics
• Mast Therapeutics
• Bayer AG
• Eli Lilly
• Acceleron Pharma
• Regen biopharma

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Anemia Drugs in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Anemia Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Anemia Drugs Market Report 2016

1 ANEMIA DRUGS OVERVIEW

1.1 Product Overview and Scope of Anemia Drugs
1.2 Classification of Anemia Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Anemia Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Anemia Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Anemia Drugs (2011-2021)
  1.5.1 Europe Anemia Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Anemia Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE ANEMIA DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Anemia Drugs Market Competition by Manufacturers
  2.1.1 Europe Anemia Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Anemia Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Anemia Drugs (Volume and Value) by Type
  2.2.1 Europe Anemia Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Anemia Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Anemia Drugs (Volume and Value) by Countries
  2.3.1 Europe Anemia Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Anemia Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Anemia Drugs (Volume) by Application

3 GERMANY ANEMIA DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Anemia Drugs Sales and Value (2011-2016)
  3.1.1 Germany Anemia Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Anemia Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Anemia Drugs Sales Price Trend (2011-2016)
3.2 Germany Anemia Drugs Sales and Market Share by Manufacturers
3.3 Germany Anemia Drugs Sales and Market Share by Type
3.4 Germany Anemia Drugs Sales and Market Share by Application

4 FRANCE ANEMIA DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Anemia Drugs Sales and Value (2011-2016)
  4.1.1 France Anemia Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Anemia Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Anemia Drugs Sales Price Trend (2011-2016)
4.2 France Anemia Drugs Sales and Market Share by Manufacturers
4.3 France Anemia Drugs Sales and Market Share by Type
4.4 France Anemia Drugs Sales and Market Share by Application

5 UK ANEMIA DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Anemia Drugs Sales and Value (2011-2016)
  5.1.1 UK Anemia Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Anemia Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Anemia Drugs Sales Price Trend (2011-2016)
5.2 UK Anemia Drugs Sales and Market Share by Manufacturers
5.3 UK Anemia Drugs Sales and Market Share by Type
5.4 UK Anemia Drugs Sales and Market Share by Application

6 RUSSIA ANEMIA DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Anemia Drugs Sales and Value (2011-2016)
  6.1.1 Russia Anemia Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Anemia Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Anemia Drugs Sales Price Trend (2011-2016)
6.2 Russia Anemia Drugs Sales and Market Share by Manufacturers
6.3 Russia Anemia Drugs Sales and Market Share by Type
6.4 Russia Anemia Drugs Sales and Market Share by Application

7 ITALY ANEMIA DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Anemia Drugs Sales and Value (2011-2016)
  7.1.1 Italy Anemia Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Anemia Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Anemia Drugs Sales Price Trend (2011-2016)
7.2 Italy Anemia Drugs Sales and Market Share by Manufacturers
7.3 Italy Anemia Drugs Sales and Market Share by Type
7.4 Italy Anemia Drugs Sales and Market Share by Application

8 SPAIN ANEMIA DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Anemia Drugs Sales and Value (2011-2016)
  8.1.1 Spain Anemia Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Anemia Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Anemia Drugs Sales Price Trend (2011-2016)
8.2 Spain Anemia Drugs Sales and Market Share by Manufacturers
8.3 Spain Anemia Drugs Sales and Market Share by Type
8.4 Spain Anemia Drugs Sales and Market Share by Application

9 BENELUX ANEMIA DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Anemia Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Anemia Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Anemia Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Anemia Drugs Sales Price Trend (2011-2016)
9.2 Benelux Anemia Drugs Sales and Market Share by Manufacturers
9.3 Benelux Anemia Drugs Sales and Market Share by Type
9.4 Benelux Anemia Drugs Sales and Market Share by Application

10 EUROPE ANEMIA DRUGS MANUFACTURERS ANALYSIS

10.1 GlaxoSmithKline
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Anemia Drugs Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 GlaxoSmithKline Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Bluebird bio
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Anemia Drugs Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Bluebird bio Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 GlycoMimetics
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Anemia Drugs Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 GlycoMimetics Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Mast Therapeutics
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Anemia Drugs Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Mast Therapeutics Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Bayer AG
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Anemia Drugs Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Bayer AG Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Eli Lilly
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Anemia Drugs Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Eli Lilly Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Acceleron Pharma
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Anemia Drugs Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Acceleron Pharma Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Regen biopharma
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Anemia Drugs Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Regen biopharma Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview

11 ANEMIA DRUGS MANUFACTURING COST ANALYSIS

11.1 Anemia Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Anemia Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Anemia Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Anemia Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ANEMIA DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Anemia Drugs Sales Forecast (2016-2021)
14.2 France Anemia Drugs Sales Forecast (2016-2021)
14.3 UK Anemia Drugs Sales Forecast (2016-2021)
14.4 Russia Anemia Drugs Sales Forecast (2016-2021)
14.5 Italy Anemia Drugs Sales Forecast (2016-2021)
14.6 Spain Anemia Drugs Sales Forecast (2016-2021)
14.7 Benelux Anemia Drugs Sales Forecast (2016-2021)
14.8 Europe Anemia Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Anemia Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anemia Drugs
Table Classification of Anemia Drugs
Figure Europe Sales Market Share of Anemia Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Anemia Drugs
Figure Europe Sales Market Share of Anemia Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Anemia Drugs Revenue and Growth Rate (2011-2021)
Figure France Anemia Drugs Revenue and Growth Rate (2011-2021)
Figure UK Anemia Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Anemia Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Anemia Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Anemia Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Anemia Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Anemia Drugs Sales and Growth Rate (2011-2021)
Figure Europe Anemia Drugs Revenue and Growth Rate (2011-2021)
Table Europe Anemia Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Anemia Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anemia Drugs Sales Share by Manufacturers
Figure 2016 Anemia Drugs Sales Share by Manufacturers
Table Europe Anemia Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Anemia Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Anemia Drugs Revenue Share by Manufacturers
Table 2016 Europe Anemia Drugs Revenue Share by Manufacturers
Table Europe Anemia Drugs Sales and Market Share by Type (2011-2016)
Table Europe Anemia Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Anemia Drugs by Type (2011-2016)
Figure Europe Anemia Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Anemia Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Anemia Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Anemia Drugs by Type (2011-2016)
Figure Europe Anemia Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Anemia Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Anemia Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Anemia Drugs by Countries (2011-2016)
Table Europe Anemia Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Anemia Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Anemia Drugs by Countries (2011-2016)
Table Europe Anemia Drugs Sales and Market Share by Application (2011-2016)
Table Europe Anemia Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Anemia Drugs by Application (2011-2016)
Figure Germany Anemia Drugs Sales and Growth Rate (2011-2016)
Figure Germany Anemia Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Anemia Drugs Sales Price Trend (2011-2016)
Table Germany Anemia Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Anemia Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Anemia Drugs Sales by Type (2015 and 2016)
Table Germany Anemia Drugs Market Share by Type (2015 and 2016)
Table Germany Anemia Drugs Sales by Application (2015 and 2016)
Table Germany Anemia Drugs Market Share by Application (2015 and 2016)
Figure France Anemia Drugs Sales and Growth Rate (2011-2016)
Figure France Anemia Drugs Revenue and Growth Rate (2011-2016)
Figure France Anemia Drugs Sales Price Trend (2011-2016)
Table France Anemia Drugs Sales by Manufacturers (2015 and 2016)
Table France Anemia Drugs Market Share by Manufacturers (2015 and 2016)
Table France Anemia Drugs Sales by Type (2015 and 2016)
Table France Anemia Drugs Market Share by Type (2015 and 2016)
Table France Anemia Drugs Sales by Application (2015 and 2016)
Table France Anemia Drugs Market Share by Application (2015 and 2016)
Figure UK Anemia Drugs Sales and Growth Rate (2011-2016)
Figure UK Anemia Drugs Revenue and Growth Rate (2011-2016)
Figure UK Anemia Drugs Sales Price Trend (2011-2016)
Table UK Anemia Drugs Sales by Manufacturers (2015 and 2016)
Table UK Anemia Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Anemia Drugs Sales by Type (2015 and 2016)
Table UK Anemia Drugs Market Share by Type (2015 and 2016)
Table UK Anemia Drugs Sales by Application (2015 and 2016)
Table UK Anemia Drugs Market Share by Application (2015 and 2016)
Figure Russia Anemia Drugs Sales and Growth Rate (2011-2016)
Figure Russia Anemia Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Anemia Drugs Sales Price Trend (2011-2016)
Table Russia Anemia Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Anemia Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Anemia Drugs Sales by Type (2015 and 2016)
Table Russia Anemia Drugs Market Share by Type (2015 and 2016)
Table Russia Anemia Drugs Sales by Application (2015 and 2016)
Table Russia Anemia Drugs Market Share by Application (2015 and 2016)
Figure Italy Anemia Drugs Sales and Growth Rate (2011-2016)
Figure Italy Anemia Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Anemia Drugs Sales Price Trend (2011-2016)
Table Italy Anemia Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Anemia Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Anemia Drugs Sales by Type (2015 and 2016)
Table Italy Anemia Drugs Market Share by Type (2015 and 2016)
Table Italy Anemia Drugs Sales by Application (2015 and 2016)
Table Italy Anemia Drugs Market Share by Application (2015 and 2016)
Figure Spain Anemia Drugs Sales and Growth Rate (2011-2016)
Figure Spain Anemia Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Anemia Drugs Sales Price Trend (2011-2016)
Table Spain Anemia Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Anemia Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Anemia Drugs Sales by Type (2015 and 2016)
Table Spain Anemia Drugs Market Share by Type (2015 and 2016)
Table Spain Anemia Drugs Sales by Application (2015 and 2016)
Table Spain Anemia Drugs Market Share by Application (2015 and 2016)
Figure Benelux Anemia Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Anemia Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Anemia Drugs Sales Price Trend (2011-2016)
Table Benelux Anemia Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Anemia Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Anemia Drugs Sales by Type (2015 and 2016)
Table Benelux Anemia Drugs Market Share by Type (2015 and 2016)
Table Benelux Anemia Drugs Sales by Application (2015 and 2016)
Table Benelux Anemia Drugs Market Share by Application (2015 and 2016)
Table Anemia Drugs Basic Information List
Table GlaxoSmithKline Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Anemia Drugs Sales Market Share (2011-2016)
Table Bluebird bio Basic Information List
Table Bluebird bio Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bluebird bio Anemia Drugs Sales Market Share (2011-2016)
Table GlycoMimetics Basic Information List
Table GlycoMimetics Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlycoMimetics Anemia Drugs Sales Market Share (2011-2016)
Table Mast Therapeutics Basic Information List
Table Mast Therapeutics Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mast Therapeutics Anemia Drugs Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Anemia Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Anemia Drugs Sales Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acceleron Pharma Anemia Drugs Sales Market Share (2011-2016)
Table Regen biopharma Basic Information List
Table Regen biopharma Anemia Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Regen biopharma Anemia Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anemia Drugs
Figure Manufacturing Process Analysis of Anemia Drugs
Figure Anemia Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anemia Drugs Major Manufacturers in 2015
Table Major Buyers of Anemia Drugs
Table Distributors/Traders List
Figure Germany Anemia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Anemia Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Anemia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Anemia Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Anemia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Anemia Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Anemia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Anemia Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Anemia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Anemia Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Anemia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Anemia Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Anemia Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Anemia Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Anemia Drugs Sales Forecast by Type (2016-2021)
Table Europe Anemia Drugs Sales Forecast by Application (2016-2021)